Pali D. Shah
Ranked 27 by citations to CLAD papers over ten years: 55 papers in the corpus, 689 citations. A bibliometric entry, not a quality judgement.
As of . Primary source: ORCID record.
Summary
Pali D. Shah appears as an author of 55 papers (3.47 fractional) in the OpenAlex corpus of CLAD-related articles published from 2016-10-11 to 2026-10-10 (retrieved 2026-10-10). Those papers have been cited 689 times in total (whole counting), which places this author at rank 27 among 8,698 author profiles after merging duplicate OpenAlex profiles. 5 of the papers list the author in the first or last position. Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "Johns Hopkins University" on the most recent corpus paper (2026). Not confirmed as current.. The corpus includes papers that only partly concern CLAD, and the counts describe publication and citation volume only. Linked papers are the author's most-cited papers matching CLAD terms in the title where possible.
Ranking method and caveats
Methodology for the researcher ranking
- Query: OpenAlex works of type article or review whose title or abstract contains "chronic lung allograft dysfunction" or "restrictive allograft syndrome", or "bronchiolitis obliterans" together with lung transplant terms. Retracted works and meeting-abstract supplements are removed.
- Window and date: works published 2016-10-11 to 2026-10-10; counts retrieved 2026-10-10 (2,461 works, 8,698 author profiles after merging).
- Counting: the rank is by total citations of the author's papers (whole counting). Fractional counts, first or last author papers and counts without the two 2019 ISHLT consensus papers are shown on each record.
- Identity: authors are identified by OpenAlex author identifier and ORCID. Duplicate profiles were merged by identical ORCID, or by compatible name plus shared institution. Only the top 30 entries were checked by hand.
- Rising researchers: a separate numbered list ordered by citations in the 5 years from 2021-10-11, for authors whose first paper in the corpus is dated 2019 or later and who have at least 5 papers in that window. It is a proxy, not a measure of career stage.
- Caveats: the corpus includes papers only partly about CLAD; consensus papers inflate some totals; recent papers are under-cited; author identifiers can be wrong; citations measure attention, not quality or clinical skill.
Details
- citation rank 10y
- 27 of 8,698 author profiles (top 100 listed)
- papers 10y
- 55
- fractional papers 10y
- 3.47
- citations 10y
- 689
- fractional citations 10y
- 38.8
- lead author papers 10y
- 5
- citations excluding two ishlt2019consensus papers
- 689
- rank excluding two ishlt2019consensus papers
- 15
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0001-6021-1027
- openalex author id
- A5110287415
- merged open alex profiles
- 4
- affiliation basis
- unverified; OpenAlex lists "Johns Hopkins University" on the most recent corpus paper (2026). Not confirmed as current.
Sources and links
- ORCID record (primary)
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) (The Journal of Heart and Lung Transplantation, 2021); 55 citations; DOI 10.1016/j.healun.2021.02.008
- Most-cited CLAD paper in corpus: Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction (American Journal of Transplantation, 2022); 30 citations; DOI 10.1111/ajt.17108
- Most-cited CLAD paper in corpus: Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death (American Journal of Transplantation, 2023); 27 citations; DOI 10.1016/j.ajt.2022.12.019
- Most-cited CLAD paper in corpus: Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study (American Journal of Respiratory and Critical Care Medicine, 2025); 24 citations; DOI 10.1164/rccm.202403-0568oc
- Most-cited CLAD paper in corpus: Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year (The Journal of Heart and Lung Transplantation, 2023); 21 citations; DOI 10.1016/j.healun.2023.02.005
Related
Links from this record
Known gaps in this record
- role or job title
- centre membership relation (not asserted)
- funding and conflicts of interest
- verified current affiliation
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.